Medac GmbH Furthers Its Commitment to Pharmacovigilance Tech, Partners with ArisGlobal

Published on: 

SaaS’ branded platform expected to help grow manufacturer’s therapeutic development processes.

Medac GmbH, a pharma manufacturer specializing in the fields of oncology and hematology, urology, and autoimmune diseases, has chosen ArisGlobal’s LifeSphere Safety—the life sciences software as a service (SaaS) provider’s branded patient treatment development software platform—to help modernize its drug safety processes.


The manufacturer plans to launch three products from LifeSphere Safety, including its flagship solution for automated case processing, LifeSphere MultiVigilance, along with Reporting and Analytics, and EV Triage.

“LifeSphere has been developed with organizations like Medac in mind; to meet global compliance, provide next-level safety insights, and operate with greater efficiency,” shares Aman Wasan, chief commercial officer, ArisGlobal. “We are pleased that medac has entrusted LifeSphere products to continue their advancement of therapeutic development processes. We are confident that medac will see incredible benefit to onboarding these solutions and positively impact safety analysis at scale.”